Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
Foundations for Explainable AI”, funded by the Dutch research council (NWO). You will be part of a team with another PhD student and two consecutive postdoctoral researchers, supervised by Dr. Tim van Erven
-
the research project “A Rigorous Framework for Transient Random Dynamics”, funded by the Dutch Research Council (NWO). You will be part of a team with a postdoctoral researcher, supervised by Dr. Maximilian
-
. The RIMLS-FNWI institute currently consists of 50 researchers (including 30 PhD candidates and postdoctoral researchers) and provides a vivid and international working environment. The institute actively
-
a larger research team of PhD candidates, postdoctoral researchers and senior researchers from various Dutch universities. Furthermore, our research team involves experts who help disseminate findings
-
many outstanding researchers from all over the world. The internationally renowned institute currently hosts more than 600 PhD candidates and postdoctoral researchers from more than 45 countries
-
, collaborative research environment, and home to many outstanding researchers from all over the world. The internationally renowned institute currently hosts more than 600 PhD candidates and postdoctoral
-
on designing motorized DNA-nanoscale building blocks and to demonstrate the first light-controlled artificial muscles and conveyor belts. The joint efforts of the PhD student and an experienced postdoctoral
-
investigator, two PhD researchers, a postdoctoral researcher, and a research assistant. We aim to create a collaborative and supportive research environment that encourages intellectual exchange and critical
-
light-controlled artificial muscles and conveyor belts. The joint efforts of the PhD student and an experienced postdoctoral researcher will aim to develop synthetic motorized nanoscale systems
-
for synthetic genomes. This project will be performed in tight collaboration with another PhD candidate, a postdoctoral fellow and a technician who will establish a mid-throughput pipeline combining in vitro and